Chronic hepatitis B: Update of recommendations

被引：372

作者：

Lok, ASF

McMahon, BJ

机构：

[1] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA

[2] Ctr Dis Control, Alaska Nat Med Ctr, Viral Hepatitis Program, Anchorage, AK USA

[3] Ctr Dis Control, Arctic Invest Program, Anchorage, AK USA

来源：

HEPATOLOGY | 2004年 / 39卷 / 03期

关键词：

D O I：

10.1002/hep.20110

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：857 / 861

页数：5

共 19 条

[1] Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].

Angus, P ;

Vaughan, R ;

Xiong, S ;

Yang, HL ;

Delaney, W ;

Gibbs, C ;

Brosgart, C ;

Colledge, D ;

Edwards, R ;

Ayres, A ;

Bartholomeusz, A ;

Locarnini, S .

GASTROENTEROLOGY, 2003, 125 (02) :292-297

[2] Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients [J].

Chan, TM ;

Fang, GX ;

Tang, CSO ;

Cheng, IKP ;

Lai, KN ;

Ho, SKN .

HEPATOLOGY, 2002, 36 (05) :1246-1252

[3] Long-term safety of adefovir dipivoxil (ADV) 10 mg once daily for chronic hepatitis B (CHB): An integrated analysis of two phase III studies [J].

Chang, TT ;

Lim, SG ;

Hadziyannis, S ;

Tassopoulos, N ;

Tong, M ;

Sievert, W ;

Fallis, R ;

Wollman, M ;

James, C ;

Fry, J ;

Chen, SS ;

Brosgart, C .

JOURNAL OF HEPATOLOGY, 2003, 38 :133-133

[4] Durability of serologic response after lamivudine treatment of chronic hepatitis B [J].

Dienstag, JL ;

Cianciara, J ;

Karayalcin, S ;

Kowdley, KV ;

Willems, B ;

Plisek, S ;

Woessner, M ;

Gardner, S ;

Schiff, E .

HEPATOLOGY, 2003, 37 (04) :748-755

[5] Histological outcome during long-term lamivudine therapy [J].

Dienstag, JL ;

Goldin, RD ;

Heathcote, EJ ;

Hann, HWL ;

Woessner, M ;

Stephenson, SL ;

Gardner, S ;

Gray, DF ;

Schiff, ER .

GASTROENTEROLOGY, 2003, 124 (01) :105-117

[6]

GUAN R, 2001, J GASTROEN HEPATOL, V16, pA60

[7] Two year results from a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B [J].

Hadziyannis, S ;

Tassopoulos, N ;

Heathcote, J ;

Chang, TT ;

Kitis, G ;

Rizetto, M ;

Marcellin, P ;

Lim, SG ;

Chen, SS ;

Wulfsohn, M ;

Wollman, M ;

Fry, J ;

Brosgart, C .

JOURNAL OF HEPATOLOGY, 2003, 38 :143-143

[8] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Tassopoulos, NC ;

Heathcote, EJ ;

Chang, TT ;

Kitis, G ;

Rizzetto, M ;

Marcellin, P ;

Lim, SG ;

Goodman, Z ;

Wulfsohn, MS ;

Xiong, S ;

Fry, J ;

Brosgart, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :800-807

[9] Clinical trial of lamivudine in children with chronic hepatitis B [J].

Jonas, MM ;

Kelley, DA ;

Mizerski, J ;

Badia, IB ;

Areias, JA ;

Schwarz, KB ;

Little, NR ;

Greensmith, MJ ;

Gardner, SD ;

Bell, MS ;

Sokal, EM ;

Alonso, EM ;

Alvarez, F ;

Balistreri, W ;

Bortolotti, F ;

Cabral, J ;

Conjeevaram, HS ;

Crissinger, KF ;

Ferreira, G ;

Fitzgerald, JF ;

Gremse, DA ;

Hann, HI ;

Harmatz, P ;

Jara, P ;

Karyda, S ;

Lewis, JD ;

Maller, E ;

Manolaki, N ;

Mohan, P ;

Murray, KF ;

Pollack, H ;

Porta, G ;

Rhoads, MJ ;

Schreiber, RA ;

Sluzewski, W ;

Sokol, R ;

Squires, R ;

Tassopoulos, N ;

Tormo, T ;

Treem, WR ;

Vajro, P ;

Weisdorf, S ;

Woynarowski, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) :1706-1713

[10] Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation [J].

Lau, GKK ;

He, ML ;

Fong, DYT ;

Bartholomeusz, A ;

Au, WY ;

Lie, AKW ;

Locarnini, S ;

Liang, R .

HEPATOLOGY, 2002, 36 (03) :702-709

← 1 2 →